L1 Capital Pty Ltd bought $28.8M of Anteris Technologies Global (AVR)
Executed Jan 22, disclosed Feb 10, 18 days later, against a two-business-day limit.
Over the 21 trading sessions from the disclosed entry session (Feb 9), the stock returned +16.2% (delay-adjusted); from the execution session (Jan 22), -6.3%. Derived: entry at the session's open, exit at the close 20 sessions later.
L1 Capital Pty Ltd (10% owner) filed 9 Form 4 reports as a reporting entity in the trailing twelve months (2 purchases, 7 sales, 2 filed past the two-business-day deadline), most often in Anteris Technologies Global Corp. (AVR). Across 1 priced purchase filing, the average 21-session return was -6.3% from execution and +16.2% from disclosure (delay-adjusted; derived). The largest single filing was $28.8M of AVR (5,000,000 sh × $5.75, as filed), executed Jan 22.
Healthcare · Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat hear…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→627,659 sh across 2 lots
Exec Aug 10
Filed Aug 12 · 6:13 AM ET AVRSALE Anteris Technologies Global Corp. $1.4M
174,721 sh × $8.10
Exec Aug 6
Filed Aug 10 · 7:24 AM ET AVRSALE Anteris Technologies Global Corp. $4.1M
495,189 sh across 2 lots
Exec Aug 4
Filed Aug 6 · 6:48 AM ET AVRSALE Anteris Technologies Global Corp. $4.3M
524,404 sh across 2 lots
Exec Jul 31
Filed Aug 4 · 6:23 AM ET AVRSALE Anteris Technologies Global Corp. $5.8M
714,138 sh across 2 lots
Exec Jul 29
Filed Jul 31 · 6:25 AM ET AVRSALE Anteris Technologies Global Corp. $3.6M
441,548 sh across 2 lots
Exec Jul 27
Filed Jul 29 · 6:40 AM ET AVRSALE Anteris Technologies Global Corp. $187K
23,000 sh × $8.13
Exec Jul 24
Filed Jul 28 · 8:34 AM ET AVRPURCHASE Anteris Technologies Global Corp. $28.8M
5,000,000 sh × $5.75
Exec Jan 22
Filed Jul 28 · 9:00 AM ET †